Processa Pharmaceuticals, Inc. Amortization of Intangible Assets
Processa Pharmaceuticals, Inc. (PCSA) reported Amortization of Intangible Assets of $788.50 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2024-03-29
- Processa Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2022-12-31 was $197.12K, a 0.00% change year-over-year.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2022-09-30 was $197.12K, a 0.73% increase year-over-year.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2022-06-30 was $197.12K, a 0.86% decline year-over-year.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2022-03-31 was $197.12K, a 0.86% decline year-over-year.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2022 was $788.50K, a 0.25% decline from fiscal 2021.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2021 was $790.49K, a 0.61% decline from fiscal 2020.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2020 was $795.33K, a 0.00% change from fiscal 2019.
- Processa Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2019 was $795.33K, a 27.94% increase from fiscal 2018.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 36 month |
|---|---|---|---|---|---|
| 2022-12-31 | $197.12K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $394.25K derived: sum of 2 quarters · filed 2024-03-29 | $591.37K derived: sum of 3 quarters · filed 2024-03-29 | $788.50K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $197.12K 10-Q · filed 2022-11-08 | $394.25K derived: sum of 2 quarters · filed 2023-08-10 | $591.37K 10-Q · filed 2023-11-13 | $788.50K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-06-30 | $197.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $394.25K 10-Q · filed 2023-08-10 | $591.37K derived: sum of 3 quarters · filed 2023-08-10 | $787.07K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $197.12K 10-Q · filed 2023-05-15 | $394.25K derived: sum of 2 quarters · filed 2023-05-15 | $589.95K derived: sum of 3 quarters · filed 2023-05-15 | $788.78K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $197.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $392.82K derived: sum of 2 quarters · filed 2023-03-30 | $591.65K derived: sum of 3 quarters · filed 2023-03-30 | $790.49K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $195.70K 10-Q · filed 2022-11-08 | $394.53K derived: sum of 2 quarters · filed 2022-11-08 | $593.37K 10-Q · filed 2022-11-08 | $792.20K derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $198.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $397.66K 10-Q · filed 2022-08-11 | $596.50K derived: sum of 3 quarters · filed 2022-08-11 | $795.33K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $198.83K 10-Q · filed 2022-05-12 | $397.66K derived: sum of 2 quarters · filed 2022-05-12 | $596.50K derived: sum of 3 quarters · filed 2022-05-12 | $795.33K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $198.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $397.66K derived: sum of 2 quarters · filed 2022-03-30 | $596.50K derived: sum of 3 quarters · filed 2022-03-30 | $795.33K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $198.83K 10-Q · filed 2021-11-12 | $397.66K derived: sum of 2 quarters · filed 2021-11-12 | $596.50K 10-Q · filed 2021-11-12 | $795.33K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $198.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $397.66K 10-Q · filed 2021-08-12 | $596.50K derived: sum of 3 quarters · filed 2021-08-12 | $795.33K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $198.83K 10-Q · filed 2021-05-13 | $397.66K derived: sum of 2 quarters · filed 2021-05-13 | $596.50K derived: sum of 3 quarters · filed 2021-05-13 | $795.33K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $198.83K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $397.66K derived: sum of 2 quarters · filed 2021-03-25 | $596.50K derived: sum of 3 quarters · filed 2021-03-25 | $795.33K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $198.83K 10-Q · filed 2020-11-12 | $397.66K derived: sum of 2 quarters · filed 2020-11-12 | $596.50K 10-Q · filed 2020-11-12 | $795.33K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $198.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $397.66K 10-Q · filed 2020-08-05 | $596.50K derived: sum of 3 quarters · filed 2020-08-05 | $796.75K derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $198.83K 10-Q · filed 2020-05-15 | $397.67K derived: sum of 2 quarters · filed 2020-05-15 | $597.92K derived: sum of 3 quarters · filed 2020-05-15 | $795.04K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $198.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $399.09K derived: sum of 2 quarters · filed 2020-03-06 | $596.21K derived: sum of 3 quarters · filed 2020-03-06 | $621.65K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $200.26K 10-Q · filed 2019-11-14 | $397.38K derived: sum of 2 quarters · filed 2019-11-14 | $422.81K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $197.12K 10-Q · filed 2018-08-14 | $222.56K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $25.43K 10-Q · filed 2019-05-14 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $0.00 derived: sum of 2 quarters · filed 2017-09-25 | $89.28K derived: sum of 3 quarters · filed 2017-09-25 | $178.57K 10-K · filed 2017-09-25 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $89.28K derived: sum of 2 quarters · filed 2017-09-08 | $178.57K 10-Q · filed 2017-09-08 | $267.86K derived: sum of 4 quarters · filed 2017-09-08 | |
| 2015-06-30 | $89.28K 10-Q · filed 2015-08-19 | $178.57K 10-Q · filed 2017-08-30 | $267.86K derived: sum of 3 quarters · filed 2017-08-07 | $357.14K derived: sum of 4 quarters · filed 2017-08-07 | |
| 2015-03-31 | $89.28K 10-Q · filed 2017-08-07 | $178.57K derived: sum of 2 quarters · filed 2017-08-07 | $267.86K derived: sum of 3 quarters · filed 2017-08-07 | $357.14K derived: sum of 4 quarters · filed 2017-08-07 | |
| 2014-12-31 | $89.29K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $178.57K derived: sum of 2 quarters · filed 2017-06-19 | $267.86K derived: sum of 3 quarters · filed 2017-06-19 | $357.14K 10-K · filed 2017-06-19 | |
| 2014-09-30 | $89.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $178.57K derived: sum of 2 quarters · filed 2015-12-01 | $267.86K 10-Q · filed 2015-12-01 | $357.14K derived: sum of 4 quarters · filed 2015-12-01 | |
| 2014-06-30 | $89.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $178.57K 10-Q · filed 2015-08-19 | $267.86K derived: sum of 3 quarters · filed 2015-08-19 | $357.14K derived: sum of 4 quarters · filed 2015-08-19 | |
| 2014-03-31 | $89.28K 10-Q · filed 2015-05-15 | $178.57K derived: sum of 2 quarters · filed 2015-05-15 | $267.86K derived: sum of 3 quarters · filed 2015-05-15 | $357.14K derived: sum of 4 quarters · filed 2015-05-15 | $535.71K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $89.29K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $178.57K derived: sum of 2 quarters · filed 2015-04-14 | $267.86K derived: sum of 3 quarters · filed 2015-04-14 | $357.14K 10-K · filed 2015-04-14 | |
| 2013-09-30 | $89.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $178.57K derived: sum of 2 quarters · filed 2014-11-13 | $267.86K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $89.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | $178.57K 10-Q · filed 2014-08-19 | |||
| 2013-03-31 | $89.28K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |